FDA Inspection
Tianjin Weijie Pharmaceutical Co., Ltd.Tianjin Weijie Pharmaceutical Co., Ltd. – FDA Inspection, Jan 11, 2018
Record Details
This FDA Inspection record concerns Tianjin Weijie Pharmaceutical Co., Ltd., with an inspection on January 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · eaae5645-8282-4363-8006-5252eec94f8f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1039729
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Tianjin Weijie Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 29, 2024 | Not classified | Office of Inspections and Investigations | |
| September 12, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 30, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tianjin Weijie Pharmaceutical Co., Ltd.
- FDA Inspection 1259239 - 2024-11-29
- FDA Inspection 898121 - 2014-09-12
- FDA Inspection 729423 - 2011-04-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.